-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Xylem, Lowers Price Target to $158

Benzinga·04/29/2026 16:58:32
Listen to the news
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $160 to $158.